Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating breast cancer

A composition and breast cancer technology, applied in the field of medicine, can solve the problems of severe toxic and side effects, and achieve the effect of reducing drug resistance and dosage

Inactive Publication Date: 2009-02-04
BEIJING SHENOGEN BIOMEDICAL
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] In view of the relatively large toxic and side effects of tamoxifen, our research found that if the dosage of tamoxifen is reduced and combined with some drugs that have the same efficacy and target different targets, these problems will likely be solved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating breast cancer
  • Medicine composition for treating breast cancer
  • Medicine composition for treating breast cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Tamoxifen was purchased from SIGMA-ALDRICH. IC-162 and IC-163 were purchased from Shanghai Yousi Biotechnology Co., Ltd.

Embodiment 2

[0025] Example 2 In Vitro Biological Testing of Pharmaceutical Compositions

[0026] Test 1:

[0027] The combined action of tamoxifen and IC-162 can induce the death of ER-positive breast cancer cell line MCF7.

[0028] experimental method:

[0029] The MCF7 cell line (purchased from the ATCC cell bank) is a breast cancer cell line that highly expresses ERα66 and ERα36, with DMEM / F12 medium (Ivitrogen) containing 10% estrogen-free fetal bovine serum, at 37 ° C, 5% CO 2 After 2 days of cultivation in the incubator. Press 1×10 4 Inoculated at a density of 60 mm in a petri dish, adding concentrations of 0 μ M, 1 μ M, 2 μ M Tamoxifen (TAM) and different concentrations of IC-162 together or different concentrations of IC-162 alone (dissolved and diluted with DMSO), and cultured for 8 days , Count the number of surviving cells with a hemocytometer. Cells were grouped according to drug type and concentration, and 5 culture dishes were grouped.

[0030] Experimental results...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine combination which is used for curing breast cancer and belongs to the chemical medicine field. The invention develops the medicine composition which contains the active ingredient of nolvadex (I) and IC-162 (II) or IC-163 (III), and uses the synergistic mechanism thereof to provide the medicine composition which has good effect on inhibiting breast cancer tumor and can correspondingly reduce the side effect of the nolvadex (I).

Description

technical field [0001] The invention belongs to the field of medicine and relates to an antineoplastic drug, especially a pharmaceutical composition for treating breast cancer. Background technique [0002] Estrogen is a steroid hormone produced by the endocrine system, which plays an important role in the reproductive system, bone tissue, cardiovascular system, immune system and central nervous system [J Cell Sci, 2003; 116(4): 585-586]. The estrogen signaling system plays an important role in the regulation of cell growth, differentiation and apoptosis. The occurrence and development of estrogen-dependent tumors, such as breast cancer, ovarian cancer and endometrial cancer, are closely related to estrogen [J Steroid Biochem.Mol.Biol., 2002, 81(1): 1-24 , J Mammary Gland Biol. Neoplasia, 1998, 3(1): 49-61, Curr. Drug Targets Immune Endocr. Metabol. Disord; 2001, 1(1): 1-12, Cancer Res., 1998, 58(23) : 5367-5373, J Psychiatry Neurosci, 2002; 27 (1): 1-27], so the research...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/352A61K31/138A61P35/00
Inventor 孟坤李靖
Owner BEIJING SHENOGEN BIOMEDICAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com